Literature DB >> 2492535

Ligand-induced desensitization of 125I-epidermal growth factor internalization.

D Kuppuswamy1, L J Pike.   

Abstract

The internalization of 125I-epidermal growth factor (EGF) by A431 cells was investigated. Control cells were able to internalize over 80% of receptor-bound 125I-EGF. By contrast, cells treated with EGF before incubation with 125I-EGF internalized only 50% of the surface-bound radioligand. The ligand-induced decrease in 125I-EGF internalization showed a dose response to EGF with half-maximal effect occurring at 3 nM. The alteration in the extent of 125I-EGF internalization did not require extended treatment with high concentrations of the hormone. When the internalization of picomolar versus nanomolar concentrations of EGF were compared, the lower concentrations of 125I-EGF were more completely internalized than the higher concentrations of radioligand. These data are consistent with the hypothesis that occupation of the EGF receptor by hormone rapidly leads to the activation of cellular processes which effectively desensitize the system to further ligand-induced internalization. The decrease in the extent of ligand internalization occurred in cells in which the protein kinase C (Ca2+/phospholipid-dependent enzyme) activity had been down-regulated by prolonged treatment with 12-O-tetradecanoyl-phorbol-13-acetate implying that the desensitization process is independent of protein kinase C. However, the effects of EGF on the extent of hormone internalization could be mimicked by the addition of A23187 and could be prevented by pretreatment of the cells with calmodulin antagonists suggesting the possibility that Ca2+-calmodulin is involved in the regulation of EGF receptor internalization in A431 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Release and binding of epidermal growth factor in the pancreas of rats.

Authors:  J Jaworek; S J Konturek; W Bielanski; J Bilski; M Hladij
Journal:  Int J Pancreatol       Date:  1992-02

2.  Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism.

Authors:  P Hoffman; P Rajakumar; B Hoffman; R Heuertz; W S Wold; C R Carlin
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Rapid desensitization and resensitization of bombesin-stimulated phospholipase D activity in Swiss 3T3 cells.

Authors:  C P Briscoe; R Plevin; M J Wakelam
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

4.  Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling.

Authors:  Marisa Martin-Fernandez; David T Clarke; Mark J Tobin; Samantha V Jones; Gareth R Jones
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

5.  Dimethyl sulphoxide induces a reduced growth rate, altered cell morphology and increased epidermal-growth-factor binding in Hep G2 cells.

Authors:  D A Vesey; J M Cunningham; A C Selden; A C Woodman; H J Hodgson
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

6.  Epidermal growth factor-stimulated calcium ion transients in individual A431 cells: initiation kinetics and ligand concentration dependence.

Authors:  T E Cheyette; D J Gross
Journal:  Cell Regul       Date:  1991-10

7.  PSMA-targeted SPECT agents: mode of binding effect on in vitro performance.

Authors:  Jessie R Nedrow-Byers; Adam L Moore; Tanushree Ganguly; Mark R Hopkins; Melody D Fulton; Paul D Benny; Clifford E Berkman
Journal:  Prostate       Date:  2012-08-21       Impact factor: 4.104

8.  Mutation of proline-1003 to glycine in the epidermal growth factor (EGF) receptor enhances responsiveness to EGF.

Authors:  S M Schuh; E P Newberry; M A Dalton; L J Pike
Journal:  Mol Biol Cell       Date:  1994-07       Impact factor: 4.138

9.  Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer.

Authors:  Shorouk Dannoon; Tanushree Ganguly; Hendry Cahaya; Jonathan J Geruntho; Matthew S Galliher; Sophia K Beyer; Cindy J Choy; Mark R Hopkins; Melanie Regan; Joseph E Blecha; Lubica Skultetyova; Christopher R Drake; Salma Jivan; Cyril Barinka; Ella F Jones; Clifford E Berkman; Henry F VanBrocklin
Journal:  J Med Chem       Date:  2016-06-13       Impact factor: 7.446

10.  Structural features of the cytoplasmic region of CD4 required for internalization.

Authors:  J Shin; C Doyle; Z Yang; D Kappes; J L Strominger
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.